| Characterization of a murine Ahr null allele: involvement of the Ah receptor in hepatic growth and development JV Schmidt, GH Su, JK Reddy, MC Simon, CA Bradfield Proceedings of the National Academy of Sciences 93 (13), 6731-6736, 1996 | 1125 | 1996 |
| Germline and somatic mutations of the STK11/LKB1 Peutz-Jeghers gene in pancreatic and biliary cancers GH Su, RH Hruban, RK Bansal, GS Bova, DJ Tang, MC Shekher, ... The American journal of pathology 154 (6), 1835-1840, 1999 | 522 | 1999 |
| mTOR and P70 S6 kinase expression in primary liver neoplasms F Sahin, R Kannangai, O Adegbola, J Wang, G Su, M Torbenson Clinical Cancer Research 10 (24), 8421-8425, 2004 | 448 | 2004 |
| Immunohistochemical labeling for dpc4 mirrors genetic status in pancreatic adenocarcinomas: a new marker of DPC4 inactivation RE Wilentz, GH Su, J Le Dai, AB Sparks, P Argani, TA Sohn, CJ Yeo, ... The American journal of pathology 156 (1), 37-43, 2000 | 399 | 2000 |
| Expression and functional significance of an additional ligand for CTLA-4 DJ Lenschow, GH Su, LA Zuckerman, N Nabavi, CL Jellis, GS Gray, ... Proceedings of the National Academy of Sciences 90 (23), 11054-11058, 1993 | 397 | 1993 |
| SPARC/osteonectin is a frequent target for aberrant methylation in pancreatic adenocarcinoma and a mediator of tumor–stromal interactions N Sato, N Fukushima, N Maehara, H Matsubayashi, J Koopmann, GH Su, ... Oncogene 22 (32), 5021-5030, 2003 | 328 | 2003 |
| A novel histone deacetylase inhibitor identified by high-throughput transcriptional screening of a compound library GH Su, TA Sohn, B Ryu, SE Kern Cancer research 60 (12), 3137-3142, 2000 | 299 | 2000 |
| PIK3CA mutations in head and neck squamous cell carcinoma W Qiu, F Schönleben, X Li, DJ Ho, LG Close, S Manolidis, BP Bennett, ... Clinical Cancer Research 12 (5), 1441-1446, 2006 | 270 | 2006 |
| PU. 1 is not essential for early myeloid gene expression but is required for terminal myeloid differentiation MC Olson, EW Scott, AA Hack, GH Su, DG Tenen, H Singh, MC Simon Immunity 3 (6), 703-714, 1995 | 239 | 1995 |
| Alterations in pancreatic, biliary, and breast carcinomas support MKK4 as a genetically targeted tumor suppressor gene GH Su, W Hilgers, MC Shekher, DJ Tang, CJ Yeo, RH Hruban, SE Kern Cancer Research 58 (11), 2339-2342, 1998 | 225 | 1998 |
| Dclk1 Defines Quiescent Pancreatic Progenitors that Promote Injury-Induced Regeneration and Tumorigenesis CB Westphalen, Y Takemoto, T Tanaka, M Macchini, Z Jiang, BW Renz, ... Cell stem cell 18 (4), 441-455, 2016 | 221 | 2016 |
| Defective B cell receptor‐mediated responses in mice lacking the Ets protein, Spi‐B GH Su, HM Chen, N Muthusamy, LA Garrett‐Sinha, D Baunoch, ... The EMBO Journal 16 (23), 7118-7129, 1997 | 210 | 1997 |
| PIK3CA mutations in intraductal papillary mucinous neoplasm/carcinoma of the pancreas F Schönleben, W Qiu, NT Ciau, DJ Ho, X Li, JD Allendorf, HE Remotti, ... Clinical Cancer Research 12 (12), 3851-3855, 2006 | 192 | 2006 |
| ACVR1B (ALK4, activin receptor type 1B) gene mutations in pancreatic carcinoma GH Su, R Bansal, KM Murphy, E Montgomery, CJ Yeo, RH Hruban, ... Proceedings of the National Academy of Sciences 98 (6), 3254-3257, 2001 | 173 | 2001 |
| Aberrant methylation of suppressor of cytokine signalling-1 (SOCS-1) gene in pancreatic ductal neoplasms N Fukushima, N Sato, F Sahin, GH Su, RH Hruban, M Goggins British journal of cancer 89 (2), 338-343, 2003 | 156 | 2003 |
| Requirement of IFI16 for the maximal activation of p53 induced by ionizing radiation N Fujiuchi, JA Aglipay, T Ohtsuka, N Maehara, F Sahin, GH Su, SW Lee, ... Journal of Biological Chemistry 279 (19), 20339-20344, 2004 | 151 | 2004 |
| Effects of 5-aza-2′-deoxycytidine on matrix metalloproteinase expression and pancreatic cancer cell invasiveness N Sato, N Maehara, GH Su, M Goggins Journal of the National Cancer Institute 95 (4), 327-330, 2003 | 150 | 2003 |
| Differing rates of loss of DPC4 expression and of p53 overexpression among carcinomas of the proximal and distal bile ducts: Evidence for a biologic distinction P Argani, A Shaukat, M Kaushal, RE Wilentz, GH Su, TA Sohn, CJ Yeo, ... Cancer 91 (7), 1332-1341, 2001 | 136 | 2001 |
| PU. 1 and Spi-B are required for normal B cell receptor–mediated signal transduction LA Garrett-Sinha, GH Su, S Rao, S Kabak, Z Hao, MR Clark, MC Simon Immunity 10 (4), 399-408, 1999 | 135 | 1999 |
| The Ets protein Spi-B is expressed exclusively in B cells and T cells during development. GH Su, HS Ip, BS Cobb, MM Lu, HM Chen, MC Simon The Journal of experimental medicine 184 (1), 203-214, 1996 | 134 | 1996 |
Ralph HrubanJohns Hopkins UniversityVerified email at jhmi.edu
